Tag Archives: BioNTech

The U.S. Food and Drug Administration on Tuesday authorized the use of a booster shot of Pfizer and BioNTech’s COVID-19 vaccine for children aged 5 to 11, making everyone in the country over the age of 5 eligible for a third shot. The U.S. Centers for Disease Control and Prevention …

The Pfizer/BioNTech COVID-19 vaccine showed 90.7% efficacy against the coronavirus in a clinical trial of children 5 to 11 years old, the U.S. drugmaker said on Friday. Sixteen children in the trial who had received a placebo got COVID-19, compared with 3 who were vaccinated, Pfizer said in briefing documents …

German company BioNTech, which in partnership with Pfizer developed one of the most widely used anti-Covid shots, says it’s preparing for the worldwide launch of its jab for younger recipients and might get approval in October. An mRNA vaccine against coronavirus for children aged between five and 11 years old …

Europe’s drug regulator has found a possible link between very rare heart inflammation and COVID-19 vaccines from Pfizer-BioNTech and Moderna, it said on Friday. The conditions, myocarditis and pericarditis, must be listed as side-effects of the two mRNA vaccines, the safety committee of the European Medicines Agency (EMA) said, adding …

Pfizer Inc said on Tuesday it will begin testing its COVID-19 vaccine in a bigger group of children under age 12 after selecting a lower dose of the shot in an earlier stage of the trial. The study will enroll up to 4,500 children at more than 90 clinical sites …

The U.S. agreed to pay $1.95 billion for 100 million doses of a vaccine made by Pfizer Inc. and BioNTech SE, the government’s latest step to lock up supplies to fight the pandemic. The U.S. will pay the companies when it receives the doses, following regulatory authorization or approval, according …

The European Union is negotiating advance purchase deals of potential COVID-19 vaccines with drugmakers Moderna, Sanofi, and Johnson & Johnson and biotech firms BioNtech and CureVac, two EU sources told Reuters. The talks follow a deal reached in June by four EU states with AstraZeneca for the upfront purchase of …

A COVID-19 vaccine developed by German biotech firm BioNTech and U.S. pharmaceutical giant Pfizer has shown potential and was found to be well tolerated in early-stage human trials, the companies said on Wednesday. The drug is one of 17 being tested on humans in a frantic global race to find …